These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38849277)

  • 1. Review of Discordance Between American Urological Association and European Association of Urology Guideline Recommendations for Testicular Cancer.
    Cazzaniga W; Pierorazio P; Heidenreich A
    Eur Urol Focus; 2024 May; 10(3):383-386. PubMed ID: 38849277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS).
    Heidenreich A; Paffenholz P; Hartmann F; Seelemeyer F; Pfister D
    Eur Urol Oncol; 2024 Feb; 7(1):122-127. PubMed ID: 37438222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma.
    Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
    Eur Urol Oncol; 2024 Jun; 7(3):319-322. PubMed ID: 37932157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Association of Urology Guidelines on Testicular Cancer: 2023 Update.
    Patrikidou A; Cazzaniga W; Berney D; Boormans J; de Angst I; Di Nardo D; Fankhauser C; Fischer S; Gravina C; Gremmels H; Heidenreich A; Janisch F; Leão R; Nicolai N; Oing C; Oldenburg J; Shepherd R; Tandstad T; Nicol D
    Eur Urol; 2023 Sep; 84(3):289-301. PubMed ID: 37183161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative Review of Clinical Guidelines for Medical and Surgical Management of Urolithiasis: Consensus and Controversy 2020.
    Jiang P; Xie L; Arada R; Patel RM; Landman J; Clayman RV
    J Urol; 2021 Apr; 205(4):999-1008. PubMed ID: 33284671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma.
    Joyce DD; Sharma V; Wymer KM; Moriarty JP; Borah BJ; Walia A; Costello BA; Pagliaro LC; Daneshmand S; Leibovich BC; Boorjian SA
    J Natl Cancer Inst; 2024 Mar; 116(3):468-475. PubMed ID: 37819776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
    Hiester A; Nini A; Arsov C; Buddensieck C; Albers P
    J Urol; 2020 Dec; 204(6):1242-1248. PubMed ID: 32717162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National management trends in clinical stage IIA nonseminomatous germ cell tumor (NSGCT) and opportunities to avoid dual therapy.
    Labbate CV; Werntz RP; Galansky LB; Packiam VT; Eggener SE
    Urol Oncol; 2020 Aug; 38(8):687.e13-687.e18. PubMed ID: 32305267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
    Hiester A; Che Y; Lusch A; Kuß O; Niegisch G; Lorch A; Arsov C; Albers P
    Eur Urol; 2023 Jul; 84(1):25-31. PubMed ID: 36372627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Association of Urology Guidelines on Testis Cancer: Important Take Home Messages.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Eur Urol Focus; 2019 Sep; 5(5):742-744. PubMed ID: 31427195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
    Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
    J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
    Alfred Witjes J; Max Bruins H; Carrión A; Cathomas R; Compérat E; Efstathiou JA; Fietkau R; Gakis G; Lorch A; Martini A; Mertens LS; Meijer RP; Milowsky MI; Neuzillet Y; Panebianco V; Redlef J; Rink M; Rouanne M; Thalmann GN; Sæbjørnsen S; Veskimäe E; van der Heijden AG
    Eur Urol; 2024 Jan; 85(1):17-31. PubMed ID: 37858453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on Testicular Cancer: 2015 Update.
    Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP; Nicolai N; Oldenburg J;
    Eur Urol; 2015 Dec; 68(6):1054-68. PubMed ID: 26297604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
    Witjes JA; Bruins HM; Cathomas R; Compérat EM; Cowan NC; Gakis G; Hernández V; Linares Espinós E; Lorch A; Neuzillet Y; Rouanne M; Thalmann GN; Veskimäe E; Ribal MJ; van der Heijden AG
    Eur Urol; 2021 Jan; 79(1):82-104. PubMed ID: 32360052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal Lymph Node Dissection as an Alternative Treatment Strategy for Low Volume, Clinical Stage II Testicular Seminoma: A Survey of Patients and Providers.
    Warncke JC; Saltzman AF; Maroni PD; Daneshmand S; Cost NG
    Urol Pract; 2019 Jul; 6(4):249-255. PubMed ID: 37317391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.
    Patel HD; Joice GA; Schwen ZR; Semerjian A; Alam R; Srivastava A; Allaf ME; Pierorazio PM
    World J Urol; 2018 Jan; 36(1):73-78. PubMed ID: 29026972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.